Home » Stocks » ShockWave Medical

ShockWave Medical, Inc. (SWAV)

Stock Price: $72.22 USD -0.13 (-0.18%)
Updated Oct 27, 2020 12:18 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 2.46B
Revenue (ttm) 51.13M
Net Income (ttm) -64.60M
Shares Out 34.00M
EPS (ttm) -2.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $72.22
Previous Close $72.35
Change ($) -0.13
Change (%) -0.18%
Day's Open 71.89
Day's Range 71.28 - 73.73
Day's Volume 87,906
52-Week Range 22.01 - 79.74

More Stats

Market Cap 2.46B
Enterprise Value 2.25B
Earnings Date (est) Nov 9, 2020
Ex-Dividend Date n/a
Shares Outstanding 34.00M
Float 28.14M
EPS (basic) -2.04
EPS (diluted) -2.12
FCF / Share -2.40
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.59M
Short Ratio 4.24
Short % of Float 9.22%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 48.03
PB Ratio 9.92
Revenue 51.13M
Operating Income -65.42M
Net Income -64.60M
Free Cash Flow -77.11M
Net Cash 207.22M
Net Cash / Share 6.09
Gross Margin 50.40%
Operating Margin -127.95%
Profit Margin -126.30%
FCF Margin -150.81%
ROA -18.83%
ROE -35.41%
ROIC -69.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 4
Overweight 0
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(15.76% upside)
Current: $72.22
Target: 83.60
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth250.05%613.38%-
Gross Profit25.775.01-1.12
Operating Income-51.84-41.20-30.87
Net Income-51.11-41.10-30.62
Shares Outstanding23.901.761.55
Earnings Per Share-2.14-23.39-19.71
Operating Cash Flow-48.11-41.47-30.35
Capital Expenditures-3.82-1.98-0.43
Free Cash Flow-51.92-43.45-30.77
Cash & Equivalents19539.6453.73
Total Debt21.9415.05-
Net Cash / Debt17324.5953.73
Book Value193-123-83.29
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name ShockWave Medical, Inc.
Country United States
Employees 284
CEO Douglas Evan Godshall

Stock Information

Ticker Symbol SWAV
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: SWAV
IPO Date March 7, 2019


ShockWave Medical, a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company operates in the United States, Germany, rest of Europe, and internationally. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.